Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BENZONATATE CAPSULES

Closed
SPE2DP-26-T-4186Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
DIBBS
CHARCOAL, ACTIVATED, SUS
Solicitation # SPE2DP-26-T-4794
This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA under solicitation number SPE2DP-26-T-4794, is a request for quotations for Activated Charcoal Suspension (NSN 6505-01-282-8880). The procurement consists of multiple line items totaling 57 bottles, with each unit being a 240 ml bottle. The contract is a fixed-price acquisition requiring delivery within 20 days to various locations, including the USS KIDD DDG 100, Fort Bragg NC, and an FPO address. All items must be delivered FOB Destination, with inspection and acceptance occurring at the destination. The technical requirements mandate that the product be stored at a controlled room temperature between 20° to 25°C and must have a 36-month shelf life, with no more than five months having elapsed between the date of manufacture and the date of delivery. Packaging must comply with DLA requirements, specifically RP001 for palletization and ASTM D3951 for commercial packaging if the material is non-hazardous. Labels must clearly display the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Offerors are subject to various federal regulations, including the Buy American Act, cybersecurity safeguarding requirements, and strict prohibitions regarding human trafficking and hazardous material handling. Quotations must be submitted by the deadline of September 8, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

in 7 days

AI Contract Overview

Show more

BENZONATATE CAPSULES, USP, 100 MG in bottles of 100 capsules each, are being procured under solicitation SPE2DP-26-T-4186 with a total contract value of $13.26 for two bottles. The item, regulated by the FDA, is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20° to 25°C (68° to 77°F), protected from light, moisture, and humidity. Packaging and labeling must strictly follow MIL-STD-2073-1E and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical acquisitions, requiring container marking with the contractor’s name, manufacturer’s name, manufacturer part number, item description, and machine-readable barcodes. Delivery is FOB destination to Building 1509, West 6th Street, Fort Stewart, GA, within 20 days after order placement, with inspection and acceptance occurring at the destination point. The contract incorporates a full suite of federal and defense acquisition regulations including clauses on cybersecurity (252.204-7012), trafficking in persons, equal opportunity, hazardous material labeling, and restrictions on covered defense telecommunications equipment. Offerors must provide a Unique Entity ID and CAGE code, represent their small business status if applicable, and comply with the nonmanufacturer rule if submitting as a reseller. All quotations must be submitted electronically via the DLA Internet Bid Board System by the deadline of July 22, 2026, and are subject to the simplified acquisition procedures under FAR 13. The contract is administered through the Defense Logistics Agency, Medical Supply Chain Pharm FSA, with payment processed via Wide Area WorkFlow and coordinated through the designated DoDAAC.

General Info

Benzonatate 100 mg capsules, 2 bottles, FOB destination, 36-month shelf life, FDA-regulated, approved manufacturers, delivery in 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4186 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
BENZONATATE CAPSULES
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE
ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea. The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
AVKARE LLC 4QGW8 P/N NDC42291-0091-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0927-01 PROFICIENT RX LP 7GU24 P/N NDC71205-0885-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017518122 0001 BT 2.000
NSN/MATERIAL:6505006601798
SPE2DP-26-T-4186
SECTION B
PR: 7017518122 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-660-1798 Quantity: 2 BT Purchase Request: 7017518122QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency